跳至主要内容
临床试验/NCT06710951
NCT06710951已完成不适用

Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface As Antiseptic for Anti Vascular Endothelial Growth Factor Intravitreal Injections

José Gerardo García Aguirre2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2021年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
试验地点
2
主要终点
Tear breaking rupture

研究概览

简要总结

Objective and subjective comparison between the use of povidone-iodine 1% vs 5% as antiseptic in patients that need anti-VEGF intravitreal injection

详细描述

Randomized, prospective clinical trial. One group was intervened with povidone-iodine at 5% and the other at 1% as antiseptic for anti-VEGF intravitreal injection. Each patient was evaluated before and after the injection of anti-VEGF for tear break up time, bulbar redness and ocular surface satining with fluorescein. Pain perception was also evaluated 15 minutes after the injection and 48 hours after.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

盲法说明

Patients did not know which percentage of povidone-iodine was utilized during their injection.

Tear breaking time and bulbar redness were automized results by Keraatopgrah. Oxford scale pre and post injection was staged by an investigator that did not know the group in which the patient was.

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having anti-VGEF intravitreal injection scheduled
  • Informed consent signed

排除标准

  • Under 45 years
  • Opacity that prevents ophthalmological evaluation and fixation
  • Patients with severe dry eye
  • Patients with signs of infection on the ocular surface
  • Allergy to iodine
  • Pregnancy

结局指标

主要结局

Tear breaking rupture

时间窗: Change from baseline measured to 15 minutes post-injection

NIKBUT was measured with Keratopgraph before and after intravitreal injection

Bulbar redness

时间窗: Change from baseline measured to 15 minutes post-injection

Bulbar redness was measured with Keratopgraph before and after intravitreal injection

次要结局

  • Oxford scale(Change from baseline measured to 15 minutes post-injection)
  • Pain analog scale(Change from baseline measured to 15 minutes post-injection)

研究者

发起方
José Gerardo García Aguirre
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

José Gerardo García Aguirre

Retina Adjunct

Asociación para Evitar la Ceguera en México

研究点 (2)

Loading locations...

相似试验